Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma

NCT02779465 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B
Carcinoma, Hepatocellular

Interventions

DRUG: Vitamin D3

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University